Regulation of PD-L1: Emerging Routes for Targeting Tumor Immune Evasion.

Wang, Yiting; Wang, Huanbin; Yao, Han; Li, Chushu; Fang, Jing-Yuan; Xu, Jie

Wang, Yiting; Wang, Huanbin; Yao, Han; Li, Chushu; Fang, Jing-Yuan; Xu, Jie.

Afiliação

Wang Y; MOH Key Laboratory of Gastroenterology and Hepatology, State Key Laboratory for Oncogenes and Related Genes, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Wang H; MOH Key Laboratory of Gastroenterology and Hepatology, State Key Laboratory for Oncogenes and Related Genes, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Yao H; MOH Key Laboratory of Gastroenterology and Hepatology, State Key Laboratory for Oncogenes and Related Genes, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Li C; MOH Key Laboratory of Gastroenterology and Hepatology, State Key Laboratory for Oncogenes and Related Genes, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Fang JY; MOH Key Laboratory of Gastroenterology and Hepatology, State Key Laboratory for Oncogenes and Related Genes, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Xu J; MOH Key Laboratory of Gastroenterology and Hepatology, State Key Laboratory for Oncogenes and Related Genes, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

Front Pharmacol ; 9: 536, 2018.

Article em En | MEDLINE | ID: mdl-29910728

Palavras-chave

PD-L1; gene expression; immunotherapy; post-translational modification; small molecular inhibitors

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Pharmacol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google